OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY

Raphael Pharmaceutical Inc.

CIK 0001415397Ticker RAPHSEC observed OTC

Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.

Open issuer dossier
Reporting & material events61

captured official filings

Registration & offering22

captured official filings

Ownership36

captured official filings

Governance0

captured official filings

WHAT THIS AUTOMATES

One evidence index instead of a manual filing hunt.

It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.

PROFESSIONAL DELIVERY LAYER

What teams can pay to automate next.

Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.

MACHINE-DETECTED FILING CHANGE RADAR

Public registration text delta

Comparing S-1 filed 2024-09-13 with S-1/A filed 2021-11-24.

Earlier SEC filingLatest SEC filing
435latest comparable sentences
130new-text candidates
141prior-text candidates not found

Tracked-term count changes

Counts are navigation signals, not conclusions. Open both official filings to determine materiality.

  • shares18 → 21+3
  • offering10 → 12+2
  • control29 → 31+2
  • dilution1 → 0-1
  • risk factor13 → 12-1
  • management13 → 14+1

Candidate disclosure excerpts

Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.

New in latest filing
  • No additional consideration will be received for the Common Stock, and therefore no registration fee is required pursuant to Rule 457(i) under the Act. (2) Represents shares of Common Stock purchased in private placements which had multiple closings between November 2020 and July 2021. (3) There is no active current public marke
  • Resale of 1,907,764 Shares of Common Stock This prospectus relates to the resale by the selling security holders named in this prospectus or their permitted transferees (the “Selling Securityholders”) of up to 1,907,764 shares of our common stock, par value $0.01 per share (“Common Stock”) issued in one o
  • The shares of Common Stock that may be sold by the Selling Securityholders are collectively referred to in this prospectus as the “Offered Securities.” We will not receive any of the proceeds from the sale by the Selling Securityholders of the Offered Securities.
Present in earlier filing, not found in latest
  • Resale of up to 5,787,027 Shares of Common Stock This prospectus relates to the resale by the selling security holders named in this prospectus or their permitted transferees (the “Selling Securityholders”) of up to 5,787,027 shares of our common stock, par value $0.01 per share (the “Common Stock”) issue
  • Of the up to 5,787,027 shares of Common Stock offered by this prospectus, 1,854,196 shares of Common Stock were previously registered but not sold under our Registration Statement on Form S-1 (File No. 333-260766) and 682,615 shares of Common Stock were previously registered and not sold under our Registration Statement on Form
  • The shares of Common Stock that may be sold by the Selling Securityholders are collectively referred to in this prospectus as the “Offered Securities.” We will not receive any of the proceeds from the sale by the Selling Securityholders of the Offered Securities.

Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.

DOWNLOAD EDITION

Save a project-ready issuer record.

US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.

  • Source-linked filing chronology and registration path
  • Machine-detected amendment and tracked-term change view
  • Official-source index for project-file archiving and downloadable CSV export

Secure checkout by PayPal.

AUTOMATED EVIDENCE SNAPSHOT

Save this source-linked record

Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.

Unlock download · US$29
OFFICIAL SEC SUBMISSIONS

Captured filing chronology

Open Evidence Snapshot →
  1. 8-K
    Reporting & material eventsOpen SEC filing →
  2. 10-Q
    Reporting & material eventsOpen SEC filing →
  3. 4
    OwnershipOpen SEC filing →
  4. 10-K
    Reporting & material eventsOpen SEC filing →
  5. 8-K
    Reporting & material eventsOpen SEC filing →
  6. 10-Q
    Reporting & material eventsOpen SEC filing →
  7. 3
    OwnershipOpen SEC filing →
  8. 10-Q
    Reporting & material eventsOpen SEC filing →
  9. 8-K
    Reporting & material eventsOpen SEC filing →
  10. 8-K
    Reporting & material eventsOpen SEC filing →
  11. 10-Q
    Reporting & material eventsOpen SEC filing →
  12. 10-K
    Reporting & material eventsOpen SEC filing →
  13. 4
    OwnershipOpen SEC filing →
  14. 4
    OwnershipOpen SEC filing →
  15. 4
    OwnershipOpen SEC filing →
  16. 3
    OwnershipOpen SEC filing →
  17. 8-K
    Reporting & material eventsOpen SEC filing →
  18. 8-K
    Reporting & material eventsOpen SEC filing →
  19. 424B3
    Registration & offeringOpen SEC filing →
  20. 10-Q
    Reporting & material eventsOpen SEC filing →
  21. EFFECT
    Registration & offeringOpen SEC filing →
  22. S-1
    Registration & offeringOpen SEC filing →
  23. 8-K
    Reporting & material eventsOpen SEC filing →
  24. 10-Q
    Reporting & material eventsOpen SEC filing →
  25. 8-K
    Reporting & material eventsOpen SEC filing →
  26. 10-Q
    Reporting & material eventsOpen SEC filing →
  27. 8-K
    Reporting & material eventsOpen SEC filing →
  28. 10-K
    Reporting & material eventsOpen SEC filing →
  29. 4
    OwnershipOpen SEC filing →
  30. 4
    OwnershipOpen SEC filing →
  31. 10-Q
    Reporting & material eventsOpen SEC filing →
  32. 10-Q
    Reporting & material eventsOpen SEC filing →
  33. EFFECT
    Registration & offeringOpen SEC filing →
  34. EFFECT
    Registration & offeringOpen SEC filing →
  35. 10-K/A
    Reporting & material eventsOpen SEC filing →
  36. 10-Q
    Reporting & material eventsOpen SEC filing →
  37. 8-K
    Reporting & material eventsOpen SEC filing →
  38. 10-K
    Reporting & material eventsOpen SEC filing →
  39. 4
    OwnershipOpen SEC filing →
  40. 4
    OwnershipOpen SEC filing →
  41. 4
    OwnershipOpen SEC filing →
  42. 4
    OwnershipOpen SEC filing →
  43. 4
    OwnershipOpen SEC filing →
  44. 8-K/A
    Reporting & material eventsOpen SEC filing →
  45. 10-Q
    Reporting & material eventsOpen SEC filing →
  46. 8-K
    Reporting & material eventsOpen SEC filing →
  47. 10-Q
    Reporting & material eventsOpen SEC filing →
  48. EFFECT
    Registration & offeringOpen SEC filing →
  49. 8-K
    Reporting & material eventsOpen SEC filing →
  50. S-1
    Registration & offeringOpen SEC filing →
  51. EFFECT
    Registration & offeringOpen SEC filing →
  52. 10-Q
    Reporting & material eventsOpen SEC filing →
  53. 10-K
    Reporting & material eventsOpen SEC filing →
  54. 3
    OwnershipOpen SEC filing →
  55. 3
    OwnershipOpen SEC filing →
  56. 3
    OwnershipOpen SEC filing →
  57. 3
    OwnershipOpen SEC filing →
  58. EFFECT
    Registration & offeringOpen SEC filing →
  59. S-1/A
    Registration & offeringOpen SEC filing →
  60. 3
    OwnershipOpen SEC filing →
Evidence boundary

Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.